Risk factors

AGNT's risk section is dominated by real estate market cyclicality, interest rate sensitivity, regulatory and antitrust pressures, and agent retention challenges.

Assurant faces heavy reliance on key distribution partners and vulnerability to catastrophe losses in property offerings.

Alarm.com relies heavily on a partner network to sell its connected property solutions, generating $939.8 million in 2024 revenue.

International sales represent 47.4% of consolidated net sales, exposing the company to global economic and regulatory risks. Acquisitions are core to growth, with goodwill and intangibles reaching $10,471.1 million or 72% of total assets. Operations depend heavily on specialized supply chains, including semiconductor chips and raw materials.

Revenue reached $299.3 million in 2024, but net losses persist at $94.3 million alongside an accumulated deficit of $457.8 million.

Ardelyx faces heavy concentration risk around the commercial success of its only two products, IBSRELA and XPHOZAH. Medicare coverage changes for XPHOZAH under the ESRD PPS threaten future revenues. Operations depend heavily on single-source contract manufacturers.

Heavy reliance on beverage container sales and concentrated customer base dominate risk profile. Significant international footprint exposes company to currency fluctuations and regional overcapacity. High debt load of $5.69 billion threatens financial flexibility. Raw material costs, especially aluminum, heavily impact profitability.

Bandwidth faces intense competition in cloud communications and regulatory scrutiny over 911 services, AI usage, and international operations. The company is exposed to customer concentration, foreign currency risks, and potential billing and pricing complexities. Cash deposits are largely uninsured, and system reliability is critical for customer retention.

Barings’ people, sponsor relationships, valuation process and conflicts are central to BBDC’s ability to invest and generate returns.

BridgeBio's core risks center on clinical trial execution, complex manufacturing of novel gene and protein therapies, and regulatory approvals for rare Mendelian diseases.

Boise Cascade faces commodity price volatility for wood products like OSB and plywood, alongside high customer concentration risks. Supply chain disruptions, raw wood fiber availability, and strict environmental regulations heavily impact their manufacturing and distribution operations.

Bunge's risk profile is heavily dominated by agricultural commodity volatility, geopolitical conflicts, and execution risks tied to the pending Viterra acquisition. Operations face significant exposure to weather events, global trade policies, regulatory changes, and Swiss corporate governance frameworks.